par Debaugnies, France 
;Azerad, Marie-Agnès ;Noubouossié, Denis;Rozen, Laurence ;Hemker, H Coenraad;Corazza, Francis ;Efira, André ;Demulder, Anne
Référence Thrombosis research, 126, 6, page (531-535)
Publication Publié, 2010-12
;Azerad, Marie-Agnès ;Noubouossié, Denis;Rozen, Laurence ;Hemker, H Coenraad;Corazza, Francis ;Efira, André ;Demulder, Anne Référence Thrombosis research, 126, 6, page (531-535)
Publication Publié, 2010-12
Article révisé par les pairs
| Résumé : | Circulating microparticles are reported to play a role in cancer hypercoagulability. The procoagulant properties of microparticles derive from the amount of tissue factor and/or phosphatidylserine that they can expose. The aim of our study is to assess the procoagulant activity, including microparticles' activity, in the plasma of newly diagnosed cancer patients with a simple assay, easy to implement in the laboratory. |
